发明名称 |
REDUCTION IN COMPLEMENT ACTIVATION AND INFLAMMATION DURING TISSUE INJURY BY CAROTENOIDS, CAROTENOID ANALOGS, OR DERIVATIVES THEREOF |
摘要 |
<p>Administering water-soluble or dispersible synthetic analogs or derivatives of astaxanthin, lutein, zeaxanthin, or lycophyll and/or other carotenoids to a subject may reduce some of the adverse effects of inflammation in a body organ or tissue. The analogs or derivatives may be incorporated into pharmaceutical, over-the-counter, or nutraceutical preparations. Administration of the analogs or derivatives described herein may reduce deposition of inflammatory mediators such as C-reactive protein, complement system proteins or the membrane attack complex (MAC) in tissues. Reduced deposition of these molecules in tissues may reduce cell damage and/or lysis in the tissues.</p> |
申请公布号 |
CA2610502(A1) |
申请公布日期 |
2006.10.05 |
申请号 |
CA20062610502 |
申请日期 |
2006.03.29 |
申请人 |
CARDAX PHARMACEUTICALS, INC. |
发明人 |
NADOLSKI, GEOFF;LOCKWOOD, SAMUEL F. |
分类号 |
A61K31/225;A61K31/341;A61K31/665;A61P9/10;A61P29/00 |
主分类号 |
A61K31/225 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|